Results 211 to 220 of about 463,847 (234)

Isoniazid (isonicotinic acid hydrazide) in the treatment of miliary and meningeal tuberculosis.

American review of tuberculosis, 1952
C. Clark, D. Elmendorf, W. U. Cawthon, C. Muschenheim, W. Mcdermott   +4 more
semanticscholar   +1 more source

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

Nature Medicine, 2013
Kevin Pethe, Pablo Bifani, Mary Jackson
exaly  

MENINGEAL TUBERCULOSIS IN CHILDREN: A REVIEW OF FORTY PATIENTS

Medical Journal of Australia, 1951
Stanley Williams, B. W. Neal
openaire   +3 more sources

Beyond macrophages: the diversity of mononuclear cells in tuberculosis

Immunological Reviews, 2014
Joel D Ernst, Ludovic Desvignes
exaly  

A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes

Nature, 2018
Francesco Vallania, Xinchun Chen, Fatoumatta Darboe   +2 more
exaly  

Glucocorticoid use, other associated factors, and the risk of tuberculosis

Arthritis Care and Research: the Official Journal of the Arthritis Health Professions Association, 2006
Susan S Jick
exaly  

The Immune Response in Tuberculosis

Annual Review of Immunology, 2013
Anne O’garra, Chloe I Bloom, Robert J Wilkinson   +2 more
exaly  

The Granuloma in Tuberculosis: Dynamics of a Host–Pathogen Collusion

Frontiers in Immunology, 2012
Ulrich E Schaible
exaly  

Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains

Frontiers in Cellular and Infection Microbiology, 2018
Changwei Wang, Shouyong Tan, Tianyu Zhang   +2 more
exaly  

Nanomedicine in Therapeutic Intervention of Tuberculosis Meningitis

Current Nanoscience, 2014
Raman Kumar, Rohit Sharma, Anil K. Sharma, Ramesh Jhorar   +3 more
openaire   +2 more sources